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EDITORIAL 
Chinese Survey Reveals Majority Support 
for Gene Editing Technology 
A Chinese scientist recently shocked the world with  
his claims that he had created the world’s first babies genetically 
edited with CRISPR. He Jiankui, a Chinese researcher, 
announced at the Human Genome Editing Conference in Hong 
Kong on 28 November 2018 that he had helped deliver a set of 
twin girls, not with the aim of creating designer babies but with 
the aim to eliminate the risk of HIV in the babies. He claimed 
that another child was also on the way. 
Although He Jiankui’s experiment has not yet been fully 
vetted and has received sceptical views from around the world, 
the development nevertheless created quite a stir. It represents 
the realisation of fears of a large section of scientists who have 
always believed that CRISPR is not yet safe to be used in human 
embryos. 
CRISPR is a tool that allows treating of heritable diseases by 
controlling which genes get expressed in plants, animals, and 
even humans. The gene editing technology can be used to delete 
undesirable traits and also holds the potential to add desirable 
traits as well. There have been several research studies on the 
safety and feasibility of treating embryos for genetic diseases, 
including cardiac diseases, beta thalassemia, rare diseases such 
as Marfan syndrome, and HIV.  
Coincidentally, just a few days before He Jiankui announced 
his startling claims, an online survey carried out by the Sun  
Yat-Sen University (SYSU) in China had revealed that a 
majority of Chinese people supported the study of gene editing 
and its legalization for the purpose of treating diseases. This is 
the first-ever poll of Chinese people’s views on the therapeutic 
uses of gene editing. 
The survey received responses from 4771 Chinese people, 
575 of whom have HIV. The research team that belonged to the 
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Guangdong Key Laboratory for Big Data Analysis and 
Simulation of Public Opinion at the Sun Yat-Sen University in 
China gauged the public’s familiarity, opinions and receptivity 
about the use and ethical considerations for gene editing in 
humans. The respondents were between 12 and 67 years old, 
with the average being 24. The results show that 68 percent of 
the people polled support the research, development and 
application of gene editing technology. The respondents  
with HIV were 89 percent in favour. However, the vast majority 
reject the use of gene editing for conditions that are not genetic 
or for non-medical purposes, such as to enhance IQ or athletic 
abilities.  
With regard to the familiarity of the respondents to the gene 
editing technologies, the survey found that the majority of the 
respondents have had relatively little discussion about gene 
editing recently. Only a minority could correctly answer all the 
four questions to test their factual knowledge about gene editing. 
The majority believe that the government should provide more 
funding for gene editing. 
In addition, the survey found that 87 percent of the Chinese 
people believe that gene editing therapeutics should be legalized, 
especially with regard to treating cardiovascular disease, 
extending life span, modifying oncogenes, reducing the genetic 
risks of dementia and thalassemia, and the prevention of HIV 
infection. However, only 24 percent people approve the use of 
gene editing for enhancing IQ, 22 percent for improving athletic 
abilities and 11 percent for altering physical appearances.  
The responses of the 579 people with HIV revealed that they 
also agree with the legalization of gene editing to treat and 
prevent diseases with more than 90% believing that gene editing 
should be legally permitted in HIV prevention. This segment of 
respondents also revealed a high willingness to use gene editing 
in disease prevention and treatment. Their agreement with the 
use of gene editing is much higher than that of the general 
public, perhaps because of their strong desire to address  
their disease conditions in order to enable them to have healthy 
HIV-negative babies. 
Elsewhere too surveys have pointed to some degree of 
agreement with gene editing technologies. A 2016 STAT-
Harvard survey revealed that a majority of U.S. people favour 
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gene therapy for clinical use among patients with serious 
diseases, but they show a conservative attitude towards 
therapeutic treatment of unborn babies. In yet another poll in 
2018 by the Pew Research Center of 2,537 U.S. adults,  
60% believe that changing an unborn baby’s genetic 
characteristics to reduce a baby’s risk of developing serious 
disease conditions over its lifetime is an appropriate application 
of gene editing. These surveys have also revealed that highly 
religious people are more likely to view gene editing negatively. 
The major Chinese public’s support to gene editing, as reflected 
in the most recent Chinese survey, is probably because a high 
proportion of Chinese people are atheists. 
It remains to be seen whether large-scale public support  
to gene editing technologies would spur more efforts at 
manipulating genetic characteristics of unborn children. The 
fears are real. 
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